Document Detail


Renewing the assault on mRNA.
MedLine Citation:
PMID:  23372488     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
Mammalian cells dislike double-stranded RNA. They interpret it as a sign of an intruder, and they can unleash a recently discovered defensive mechanism to deal with the problem - they chop the invader into little pieces and use the remnants, called small interfering RNA, to identify and destroy the invader and its progeny. This process, known as RNA interference, may lend itself to new treatments for a wide range of diseases. RNA interference, however, resembles two therapies studied during the 1990s, antisense and ribozymes, in that the gene-silencing target is messenger RNA (mRNA). Is RNA interference really the Next Big Thing - or just a variation on an older but still intriguing theme?
Authors:
Jack McCain
Related Documents :
18093978 - Nuclear tumor necrosis factor receptor-associated factor 6 in lymphoid cells negatively...
21084838 - Combination of the somatic cell nuclear transfer method and rnai technology for the pro...
18505338 - V-myb suppresses phorbol ester- and modifies retinoic acid-induced differentiation of h...
10482978 - How can oncogenic transcription factors cause cancer: a critical review of the myb story.
8223478 - In vivo control of nf-kappa b activation by i kappa b alpha.
19820098 - Structure/function analysis of the pantoea stewartii quorum-sensing regulator esar as a...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Biotechnology healthcare     Volume:  1     ISSN:  1554-169X     ISO Abbreviation:  Biotechnol Healthc     Publication Date:  2004 Mar 
Date Detail:
Created Date:  2013-02-01     Completed Date:  2013-02-04     Revised Date:  2013-04-12    
Medline Journal Info:
Nlm Unique ID:  101241418     Medline TA:  Biotechnol Healthc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  44-53     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  How well are specialty injectable drugs managed?
Next Document:  The Long and Winding Road To Biologic Follow-ons.